Failure of an ACE inhibitor to improve exercise tolerance - A randomized study of trandolapril

被引:13
作者
Hampton, JR [1 ]
Cowley, AJ
Wnuk-Wojnar, AM
机构
[1] Univ Nottingham Hosp, Queens Med Ctr, Div Cardiovasc Med, Nottingham NG7 2UH, England
[2] Slaskiej Akad Med, Inst Kardiol, Klin Kardiol 1, Katowicach, Poland
关键词
ACE inhibitors; exercise duration; heart failure; trandolapril;
D O I
10.1053/euhj.1998.1241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There has been conflicting evidence of the effect of angiotensin-converting enzyme (ACE) inhibitors on exercise tolerance. Meta-analysis of published results has suggested that a beneficial effect of ACE inhibitors is demonstrated if a trial design is adequate. Setting Multicentre International Trial. Methods In a double-blind, randomized, multicentre trial, 292 patients with moderate (New York Heart Association Grades II and III) heart failure were treated with trandolapril or placebo in addition to diuretics, and followed for 16 weeks. Exercise tolerance on a treadmill was assessed at baseline and after 4, 8, 12 and 16 weeks of treatment. Both a modified Bruce and a modified Naughton protocol were used. Results Exercise tolerance improved in both treatment groups, with no significant benefit from trandolapril treatment. Conclusion Trandolapril does not in tolerance as measured by treadmill testing.
引用
收藏
页码:1823 / 1828
页数:6
相关论文
共 14 条
[1]  
BALL SG, 1993, LANCET, V342, P821
[2]   A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].
COHN, JN ;
JOHNSON, G ;
ZIESCHE, S ;
COBB, F ;
FRANCIS, G ;
TRISTANI, F ;
SMITH, R ;
DUNKMAN, WB ;
LOEB, H ;
WONG, ML ;
BHAT, G ;
GOLDMAN, S ;
FLETCHER, RD ;
DOHERTY, J ;
HUGHES, CV ;
CARSON, P ;
CINTRON, G ;
SHABETAI, R ;
HAAKENSON, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310
[3]  
COLLINS R, 1995, LANCET, V345, P669
[4]   FLOSEQUINAN IN HEART-FAILURE - ACUTE HEMODYNAMIC AND LONGER TERM SYMPTOMATIC EFFECTS [J].
COWLEY, AJ ;
WYNNE, RD ;
STAINER, K ;
FULLWOOD, L ;
ROWLEY, JM ;
HAMPTON, JR .
BRITISH MEDICAL JOURNAL, 1988, 297 (6642) :169-173
[5]  
COWLEY AJ, 1994, BRIT HEART J, V72, P226
[6]   Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure [J].
Hampton, JR ;
vanVeldhuisen, DJ ;
Kleber, FX ;
Cowley, AJ ;
Ardia, A ;
Block, P ;
Cortina, A ;
Cserhalmi, L ;
Follath, F ;
Jensen, G ;
Kayanakis, J ;
Lie, KI ;
Mancia, G ;
Skene, AM .
LANCET, 1997, 349 (9057) :971-977
[7]   A CLINICAL-TRIAL OF THE ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR TRANDOLAPRIL IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION [J].
KOBER, L ;
TORPPEDERSEN, C ;
CARLSEN, JE ;
BAGGER, H ;
ELIASEN, P ;
LYNGBORG, K ;
VIDEBEK, J ;
COLE, DS ;
AUCLERT, L ;
PAULY, NC ;
ALIOT, E ;
PERSSON, S ;
CAMM, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1670-1676
[8]  
Narang R, 1996, EUR HEART J, V17, P120
[9]   EFFECT OF ORAL MILRINONE ON MORTALITY IN SEVERE CHRONIC HEART-FAILURE [J].
PACKER, M ;
CARVER, JR ;
RODEHEFFER, RJ ;
IVANHOE, RJ ;
DIBIANCO, R ;
ZELDIS, SM ;
HENDRIX, GH ;
BOMMER, WJ ;
ELKAYAM, U ;
KUKIN, ML ;
MALLIS, GI ;
SOLLANO, JA ;
SHANNON, J ;
TANDON, PK ;
DEMETS, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1468-1475
[10]  
PACKER M, 1993, CIRCULATION, V88, P1610